TearLab Refractive Surgery Dry Eye Study

NCT ID: NCT01176045

Last Updated: 2016-02-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

128 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to determine how pre \& post-operative tear osmolarity levels relate to rates of dry eye symptoms related to refractive surgery and if differences exist in patients who are pre-treated with ocular lubricants vs. those treated only post-operatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dry eye disease is a common and major source of disability, whether occurring as a primary disorder or as a component of other diseases and its onset may be triggered or modified by exposure to systemic drugs, contact lens wear, ocular surgery and adverse environmental and work conditions. The development of a reliable, highly sensitive and specific test for the clinical diagnosis of dry eye is a major unmet clinical need, particularly to differentiate it from common conditions such as ocular allergy which exhibit similar presenting symptoms. Tear hyper-osmolarity is central to the dry eye disease process and the measurement of tear osmolarity could serve not only as a highly accurate diagnostic test but also as a measure of disease severity and a means to monitor treatment efficacy.

Recently, there have been reports in the literature regarding dry eye disease; both early and chronic following refractive surgery, with many cases potentially being previously inadvertently undiagnosed dry eye disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-surgical treatment

Patients who are pre \& post-surgical treated with ocular lubricants.

No interventions assigned to this group

Non-presurgical treatment

Patients who are only post-surgical treated with ocular lubricants

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, twenty-one years of age or older.
* Confirmed diagnosis of refractive error receiving LASIK surgery.
* Patient motivation and willingness to cooperate with the investigator and ability to return for all visits during the study.

Exclusion Criteria

* Compromised cognitive ability that may be expected to interfere with study compliance.
* Clinically significant eyelid deformity or eyelid movement disorder that is caused by conditions such as notch deformity, incomplete lid closure, entropion, ectropion, hordeola or chalazia.
* Previous ocular disease leaving sequelae or requiring current topical eye therapy other than for DED, including, but not limited to: active corneal or conjunctival infection of the eye and ocular surface scarring.
* Active ocular allergy
* Patients requiring punctual occlusion prior to surgery
* Patients requiring cyclosporine ophthalmic emulsion prior to surgery
* Known hypersensitivity to any of the agents used in testing
* Ophthalmologic drop use within 2 hours of any visit
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TLC Laser Eye Center

UNKNOWN

Sponsor Role collaborator

Abbott Medical Optics

INDUSTRY

Sponsor Role collaborator

TearLab Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Owen, OD

Role: STUDY_DIRECTOR

TLC The Laser Eye Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Connecticut TLC

Fairfield, Connecticut, United States

Site Status

Westchester TLC

Westchester, Illinois, United States

Site Status

Oklahoma City TLC

Oklahoma City, Oklahoma, United States

Site Status

Tulsa TLC

Tulsa, Oklahoma, United States

Site Status

Kremer Eye Center

King of Prussia, Pennsylvania, United States

Site Status

San Antonio TLC

San Antonio, Texas, United States

Site Status

Salt Lake City TLC

Salt Lake City, Utah, United States

Site Status

Reston TLC

Reston, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TP00087

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Laser Treatment of the Crystalline Lens
NCT01001117 UNKNOWN PHASE2/PHASE3
Long-term LASIK Follow up Study
NCT01695642 COMPLETED